1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. KYMERA THERAPEUTICS INC
Kymera Therapeutics Inc XNAS: KYMR
45.87 -0.57 (-1.23%)
758.8K
XNAS Volume

XNAS 20 Jun, 2025 4:01 PM (EDT)

Board Meeting
The next board meeting for Kymera Therapeutics Inc is on 25 Jun 2025 for the purpose of Kymera Therapeutics Inc Annual General Meeting for 2025 See details

Kymera Therapeutics Inc - KYMR - stock price prediction, stock price target, analyst ratings from 20 analysts

Kymera Therapeutics Inc has a share price target of US$ 62, revenue growth forecast of 60.0%, and profit growth estimate of -29.7% for FY25, based on top 20 analyst calls.